TG and neoplasm: Aggressive therapy is followed by serial monitoring of serum thyroglobulin levels and frequent whole body 131I scans as elevated serum thyroglobulin levels and iodine uptake are key markers for monitoring tumor recurrence [6, 14, 30, 31].